Professor Yadollah Omidi (PharmD; PhD)
Professor of Drug Delivery and Targeting: Pharmaceutical Nanobiotechnology
Editor-in-chief of BioImpacts (BI)
Editorial Board of: Daru; Journal of Ophthalmic and Vision Research;
International Journal for Biotechnology and Molecular Biology Research
Member of: Iranian Academy of Medical Sciences
Dr Omidi obtained his PharmD degree from the Faculty of Pharmacy, Tabriz University of Medical Sciences (TUOMS), Tabriz, Iran in 1991. He was then worked as a lecturer in TUOMS, Tabriz, Iran (1992-1999). Having awarded a full scholarship for a PhD degree in the field of Pharmaceutical Cell Biology and Biotechnology, he obtained his PhD from the Welsh School of Pharmacy, Cardiff University, Cardiff, UK in 2003. As an academic member, he has worked in the Center for Genome-based Therapeutics, Cardiff University, UK (2003-2004) investigating on the gene-based nanomedicines. Dr Omidi, as the founding director of the Research Center for Pharmaceutical Nanotechnology (RCPN) set up RCPN in 2004 as the first high-tech center for the nanomedicine researches in Iran. RCPN has nationally been recognized as a center of excellence, pioneering cutting age researches in the field of pharmaceutical nanobiotechnology with the state-of-the-art facilities. Dr Omidi is working as a full Professor of Pharmaceutical Sciences, focusing on Pharmaceutical Nanobiotechnology and Drug Delivery and Targeting at TUOMS Faculty of Pharmacy. While supervising MSc, PharmD and PhD students and serving as the head of the National Institute of Medical Researches at TUOMS, he teaches several subjects such as biopharmaceutics, pharmacogenomics, pharmaceutical nanotechnology and biotechnology and medical and pharmaceutical English language. In 2008, he founded the School of Advanced Biomedical Sciences in Tabriz-Iran, and acted as the Dean of School till 2011. He has worked as a visiting professor at the University of Pennsylvania (UPenn) leading an international program on multifunctional nanomedicine for targeted therapy of ovarian cancer (2011-2013). He is member of the National Academy of Medical Sciences and has published over 100 papers and book chapters with h-index of 23. He has proven leadership, integrating several scientific domains and disciplines towards translational researches in targeted therapy and molecular detection of diseases. As an internationally well-known scientist, Dr Omidi serves editorial board of several scientific journals while acting as EIC of BioImpacts - an internationl journal for translational and bench-to-bedside researches.
Click to see his publication records at the Google Scholar or PubMed.
His research interests include:
- Molecular pharmaceuticals for crossing biological barriers (BBB, BOB)
- Multifunctional nanomedicines and multimodal theranostics
- Molecular Therapy (mAbs, bispecific antibody scaffolds, molecular vaccines)
- Gene/cell therapy and regenerative medicine
- Nanobiosensors for early detection of diseases
Selected Book Chapters
Omidi Y. and Davaran, Impacts of biodegradable polymers - towards biomedical applications, in: A Handbook of Biopolymers: Synthesis, Degradation and Applications, Sharma, S., Royal Society of Chemistry (RSC), (Scheduled 2011).
Khani S., Barar J., Movafeghi A. and Omidi Y., Production of anticancer secondary metabolites: impacts of bioprocess engineering, in: Biotechnological production of plant secondary metabolites, Orhan I. (ed.), Bentham Science Publisher (Scheduled 2011).
Omidi Y., Barar J., Hamzeiy H., Nanomedicines Impacts in Ocular Delivery and Targeting, in: Nanotechnology in human health care. (ISBN: 981426721X),Sahoo, S. (ed), Pan Stanford Publishing, Singapore, (Scheduled 2010).
Omidi, Y., Gumbleton, M., “Biological Membranes and Barriers”, in: Biomaterials for Delivery and Targeting of Proteins Nucleic Acids, Mahato, R.I. (ed.), CRC Press, New York, pp. 232-274,(2005).
Jaymand M, Hatamzadeh M, Omidi Y. Modification of polythiophene by the incorporation of processable polymeric chains: Recent progress in synthesis and applications. Progress in Polymer Science. 2015.
Barar J, Kafil V, Majd MH, Barzegari A, Khani S, Johari-Ahar M, et al. Multifunctional mitoxantrone-conjugated magnetic nanosystem for targeted therapy of folate receptor-overexpressing malignant cells. Journal of Nanobiotechnology. 2015;13.
Kafil V, Eskandani M, Omidi Y, Nazemiyeh H, Barar J. Abietane diterpenoid of Salvia Sahendica Boiss and Buhse potently inhibits MCF-7 breast carcinoma cells by suppression of PI3K/AKT pathway. RSC Advances. 2015;5:18041-50.
Johari-Ahar M, Rashidi M-R, Barar J, Agaie M, Mohammadnejad D, Ramazani A, et al. An ultra-sensitive impedimetric immunosensor for detection of serum antigen CA-125 in ovarian cancer patients. Nanoscale. 2015;7:3768-79.
Zhao A, Tohidkia MR, Siegel DL, Coukos G, Omidi Y. Phage antibody display libraries: a powerful antibody discovery platform for immunotherapy. Critical reviews in biotechnology. 2014 (0):1-14.